Evidence map›Paper›PMID 18082674›Full record

ArticleCellular immunology2007

Retinoic acid promotes mouse splenic B cell surface IgG expression and maturation stimulated by CD40 and IL-4.

Qiuyan Chen, A Catharine Ross

Open access · greenAbstract read
In one paragraph

Article in Cellular immunology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 38 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Observational
  6. Innate Mechanisms in Selective IgA Deficiency.Frontiers in immunology · 2021
    Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. All- Trans-Retinoic Acid Augments the Histopathological Outcome of Neuroinflammation and Neurodegeneration in Lupus-Prone MRL/lpr Mice.The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society · 2017
    Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Vitamin A and retinoic acid in T cell-related immunity.The American journal of clinical nutrition · 2012
    Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Qiuyan ChenDepartment of Nutritional Sciences, The Pennsylvania State University, 126-S Henderson Building, University Park, PA 16802, USA.
A Catharine Ross
Pennsylvania State University · US

Funding

VITAMIN A NUTRITIONAL STATUS AND IMMUNE FUNCTIONR01DK041479 · NIDDK · PENNSYLVANIA STATE UNIVERSITY-UNIV PARK · PI ROSS, A. CATHARINE · 1989 to 2015
$4.0M
Retinoid Nutritional Status and Immune FunctionR56DK041479 · NIDDK · PENNSYLVANIA STATE UNIVERSITY, THE · PI ROSS, A. CATHARINE · 2012 to 2012
$158k
NIDDK NIH HHS DK-41479NIDDK NIH HHS R01 DK041479NIDDK NIH HHS R56 DK041479
6 · The paper itself

Abstract

Retinoic acid (RA) increases antibody production in vivo but its role in B-cell activation is unclear. In a model of purified mouse splenic B cells stimulated by CD40 coreceptor (as a surrogate of T cell co-stimulation), IL-4, a principal Th-2 cytokine, and ligation of the B-cell antigen receptor, CD40 engagement or IL-4 alone induced B-cell activation indicated by increased Ig gamma1 germline transcripts, cell proliferation, and surface (s)IgG1 expression, while triple stimulation with the combination of anti-CD40/IL-4/anti-mu synergized to heighten B-cell activation. Although RA was growth inhibitory for anti-CD40-activated B cells, RA increased the proportion of B cells that had more differentiated phenotypes, such as expression of higher level of activation-induced deaminase, Blimp-1, CD138/syndecan-1 and sIgG1. Overall, RA can promote B-cell maturation at the population level by increasing the number of sIgG1 and CD138 expressing cells, which may be related to the potentiation of humoral immunity in vivo.

Indexed as

AnimalsB-LymphocytesCD40 AntigensCell DifferentiationCell DivisionCells, CulturedFemaleGene Expression RegulationImmunoglobulin Class SwitchingImmunoglobulin GInterleukin-4MaleMiceNucleoside DeaminasesPositive Regulatory Domain I-Binding Factor 1Repressor ProteinsCD40 AntigensImmunoglobulin GInterleukin-4Nucleoside DeaminasesPositive Regulatory Domain I-Binding Factor 1Prdm1 protein, mouseRepressor ProteinsSyndecan-1Transcription FactorsTretinoin

Identifiers

PMID18082674
PMCPMC2262177
OpenAlexW2132077640

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.